Biotage AB (publ) (BITGF)
USD 11.5
(0.0%)
USD 11.5
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 184.64 Million USD | 23.47% |
| 2022 | 149.55 Million USD | 10.25% |
| 2021 | 135.64 Million USD | 1.99% |
| 2020 | 133 Million USD | 13.04% |
| 2019 | 117.65 Million USD | 14.51% |
| 2018 | 102.74 Million USD | 12.44% |
| 2017 | 91.37 Million USD | 24.29% |
| 2016 | 73.52 Million USD | 1.52% |
| 2015 | 72.41 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 490 Million USD | 935.38% |
| 2024 Q2 | 47.32 Million USD | 5.56% |
| 2024 Q1 | 44.83 Million USD | -29.36% |
| 2023 Q1 | 34.61 Million USD | -5.6% |
| 2023 Q4 | 63.46 Million USD | 54.98% |
| 2023 FY | 183.77 Million USD | 22.89% |
| 2023 Q3 | 40.94 Million USD | 8.47% |
| 2023 Q2 | 37.75 Million USD | 9.04% |
| 2022 Q1 | 40.99 Million USD | 9.19% |
| 2022 Q4 | 36.67 Million USD | 1.95% |
| 2022 Q3 | 35.96 Million USD | -6.51% |
| 2022 FY | 149.55 Million USD | 10.25% |
| 2022 Q2 | 38.47 Million USD | -6.15% |
| 2021 Q4 | 37.54 Million USD | 8.17% |
| 2021 Q2 | 35.48 Million USD | 9.93% |
| 2021 FY | 135.64 Million USD | 1.99% |
| 2021 Q1 | 32.27 Million USD | 0.0% |
| 2021 Q3 | 34.7 Million USD | -2.18% |
| 2020 FY | 133 Million USD | 13.04% |
| 2019 FY | 117.65 Million USD | 14.51% |
| 2018 FY | 102.74 Million USD | 12.44% |
| 2017 FY | 91.37 Million USD | 24.29% |
| 2016 FY | 73.52 Million USD | 1.52% |
| 2015 FY | 72.41 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| American Medical Technologies Inc. | 3.19 Million USD | -5685.649% |
| Ansell Limited | 1.61 Billion USD | 88.597% |
| Ansell Limited | 1.61 Billion USD | 88.597% |
| BG Medicine, Inc. | - USD | -Infinity% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 135.05 Thousand USD | -136620.213% |
| Psykey, Inc. | 419.29 Thousand USD | -43937.187% |
| ConvaTec Group Plc | 2.19 Billion USD | 91.584% |
| ConvaTec Group Plc | 2.14 Billion USD | 91.381% |
| Encision Inc. | 6.58 Million USD | -2703.686% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 1.82 Million USD | -10018.086% |
| LifePoint, Inc. | -18.5 Thousand USD | 998194.503% |
| Medite Cancer Diagnostics, Inc. | 6.81 Million USD | -2610.223% |
| Paradigm Medical Industries, Inc. | 772 Thousand USD | -23818.068% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 986.22 Thousand USD | -18622.748% |
| Reflect Scientific, Inc. | 1.08 Million USD | -16994.552% |
| SmileDirectClub, Inc. | 470.74 Million USD | 60.775% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 1.87 Billion USD | 90.134% |
| SheerVision, Inc. | 3.49 Million USD | -5176.536% |
| United Health Products, Inc. | - USD | -Infinity% |
| Vasamed, Inc. | 1.38 Million USD | -13219.504% |
| Wearable Health Solutions, Inc. | 745.09 Thousand USD | -24681.803% |
| Yubo International Biotech Limited | 104.28 Thousand USD | -176963.839% |